NORDIC NANOVECTOR AS has a total of 39 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in China, Canada and Republic of Korea. Its main competitors in its focus markets pharmaceuticals and biotechnology are THERAVAC PHARMACEUTICALS AB, TAP PHARMACEUTICALS INC and IMMUNOMEDICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | Canada | 3 | |
#3 | Republic of Korea | 3 | |
#4 | Mexico | 3 | |
#5 | Philippines | 3 | |
#6 | Singapore | 3 | |
#7 | United States | 3 | |
#8 | WIPO (World Intellectual Property Organization) | 3 | |
#9 | Brazil | 2 | |
#10 | EPO (European Patent Office) | 2 | |
#11 | Hong Kong | 2 | |
#12 | Israel | 2 | |
#13 | Japan | 1 | |
#14 | Norway | 1 | |
#15 | New Zealand | 1 | |
#16 | Serbia | 1 | |
#17 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Larsen Roy H | 33 |
#2 | Dahle Jostein | 23 |
#3 | Jostein Dahle | 6 |
#4 | Bruland Oeyvind S | 6 |
#5 | Repetto-Llamazares Ada | 6 |
#6 | Bruland Oyvind S | 6 |
#7 | Roy H Larsen | 4 |
#8 | Bruland Øyvind S | 3 |
#9 | Oyvind S Bruland | 2 |
#10 | Øyvind S Bruland | 1 |
Publication | Filing date | Title |
---|---|---|
US2014348745A1 | Chimeric therapeutic anti - cd37 antibodie hh1 | |
NO20100143A1 | Radioimmune conjugates, pharmaceutical compositions and kits comprising the same and their use |